Published in EMBO J on January 01, 1983
Murine T cell receptor beta chain is encoded on chromosome 6. J Exp Med (1984) 1.16
Production and characterization of cloned T-cell hybridomas that are responsive to Rickettsia conorii antigens. Infect Immun (1986) 1.10
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70
Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci U S A (1979) 72.18
Transcriptional control in the production of liver-specific mRNAs. Cell (1981) 9.35
5' flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains. Cell (1980) 4.62
Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes. Nature (1981) 4.26
Organization of the constant-region gene family of the mouse immunoglobulin heavy chain. Cell (1982) 3.72
Identification of DNA fragments carrying ecotropic proviruses of AKR mice. Proc Natl Acad Sci U S A (1979) 3.64
Evidence for the linkage of the IGC H locus to a gene controlling the idiotypic specificity of anti-p-azophenylarsonate antibodies in strain A mice. J Exp Med (1973) 3.18
Antigen-binding, idiotypic T-lymphocyte receptors. Contemp Top Immunobiol (1977) 3.00
Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. Proc Natl Acad Sci U S A (1980) 2.57
Antigen receptors of T helper cells. Contemp Top Immunobiol (1977) 2.54
Immunoglobulin messenger RNAs in murine cell lines that have characteristics of immature B lymphocytes. Cell (1979) 2.52
Diversity of germ-line immunoglobulin VH genes. Nature (1981) 2.47
Organization and evolution of immunoglobulin VH gene subgroups. Proc Natl Acad Sci U S A (1982) 2.18
Linkage analyses of murine immunoglobulin heavy chain and serum prealbumin genes establish their location on chromosome 12 proximal to the T (5;12) 31H breakpoint in band 12F1. Proc Natl Acad Sci U S A (1980) 2.03
Molecular cloning of mouse immunoglobulin heavy chain messenger ribonucleic acids coding for mu, alpha, gamma 1, gamma 2a, and gamma 3 chains. Biochemistry (1980) 1.60
Helper and killer T cells do not express B cell immunoglobulin joining and constant region gene segments. J Exp Med (1980) 1.42
Mendelian segregation of a mouse antibody idiotype. Eur J Immunol (1973) 1.37
Mechanism of antigen binding by T cells. H-2(I-A)-restricted binding of antigen plus Ia by helper cells. Eur J Immunol (1980) 1.37
Immunoglobulin heavy chain gene rearrangement and transcription in murine T cell hybrids and T lymphomas. Proc Natl Acad Sci U S A (1982) 1.35
H-2-restricted antigen binding by a hybridoma clone that produces antigen-specific helper factor. Proc Natl Acad Sci U S A (1981) 1.21
Polymorphism of germ-line immunoglobulin VH genes correlates with allotype and idiotype markers. Eur J Immunol (1981) 1.17
A family of T-cell alloantigens linked to Igh-1. Nature (1981) 1.15
Allotype-linked genetic control of a polymorphic VH framework framework determinant on mouse T-helper cell receptors. Nature (1980) 1.06
Two separate genes regulate self-Ia and carrier recognition in H-2-restricted helper factors secreted by hybridoma cells. J Exp Med (1981) 0.99
H-2-restricted helper factor secreted by clone hybridoma cells. J Exp Med (1981) 0.98
Expression of an antigen receptor on T cells does not require recombination at the immunoglobulin JH-C mu locus. Proc Natl Acad Sci U S A (1981) 0.94
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature (1985) 6.86
Sequence of chicken ovalbumin mRNA. Nature (1978) 6.73
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity (1998) 6.07
Nucleotide sequence of the rat skeletal muscle actin gene. Nature (1982) 3.81
Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res (1994) 3.54
Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res (1998) 3.36
DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene (2001) 3.28
Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci U S A (1998) 3.27
Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J (1985) 3.18
A single gene and a pseudogene for the cellular tumour antigen p53. Nature (1984) 2.98
Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol (1993) 2.96
Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J (1984) 2.94
Skeletal muscle actin mRNA. Characterization of the 3' untranslated region. Nucleic Acids Res (1981) 2.67
Localization of gene for human p53 tumour antigen to band 17p13. Nature (1986) 2.56
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
Diversity of germ-line immunoglobulin VH genes. Nature (1981) 2.47
All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. J Biol Chem (1989) 2.46
Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element. Nature (1982) 2.45
A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol (2001) 2.33
Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci U S A (1983) 2.23
Simple DNA sequences in homologous flanking regions near immunoglobulin VH genes: a role in gene interaction? Nucleic Acids Res (1982) 2.19
Differential mRNA stability to reticulocyte ribonucleases correlates with 3' non-coding (U)nA sequences. Eur J Biochem (1988) 2.19
The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci U S A (1986) 2.18
Organization and evolution of immunoglobulin VH gene subgroups. Proc Natl Acad Sci U S A (1982) 2.18
The 5' region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element. EMBO J (1985) 2.17
Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development (1991) 2.16
Developmental expression of c-kit, a proto-oncogene encoded by the W locus. Development (1990) 1.99
Homology between an endogenous viral LTR and sequences inserted in an activated cellular oncogene. Nature (1983) 1.98
Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci U S A (1989) 1.97
A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. EMBO J (1992) 1.93
General method for the detection of cells producing antibodies against haptens and proteins. Nature (1970) 1.92
Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. EMBO J (1989) 1.90
Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm (Vienna) (2004) 1.89
The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci U S A (1989) 1.86
Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood (1989) 1.85
Localization of antibody-combining sites within the variable portions of heavy and light chains. Proc Natl Acad Sci U S A (1972) 1.84
Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha. Mol Cell Biol (1988) 1.77
Antigen-induced conformational changes in antibodies and their Fab fragments studied by circular polarization of fluorescence. Proc Natl Acad Sci U S A (1975) 1.76
A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci U S A (1999) 1.75
Evolutionary aspects of immunoglobulin heavy chain variable region (VH) gene subgroups. Proc Natl Acad Sci U S A (1983) 1.72
A general method for the specific isolation of peptides containing modified residues, using insoluble antibody columns. Biochemistry (1971) 1.70
Common peptides from the N-terminal half of heavy chain of immunoglobulin G from normal rabbit serum and a specific antibody. Biochem J (1968) 1.69
Kinetic mapping of the antibody combining site by chemical relaxation spectrometry. Biochemistry (1974) 1.68
An active antibody fragment (Fv) composed of the variable portions of heavy and light chains. Biochemistry (1973) 1.68
Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. Mol Cell Biol (1988) 1.67
Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas. Nature (1984) 1.66
Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab (1996) 1.65
The CC2D1A, a member of a new gene family with C2 domains, is involved in autosomal recessive non-syndromic mental retardation. J Med Genet (2005) 1.65
Cloning and expression of a widely expressed receptor tyrosine phosphatase. Proc Natl Acad Sci U S A (1990) 1.61
Nucleotide sequence analysis identifies the human c-sis proto-oncogene as a structural gene for platelet-derived growth factor. Cell (1984) 1.61
Platelet-derived growth factor-A and its receptor are expressed in separate, but adjacent cell layers of the mouse embryo. Development (1992) 1.61
Fibroblast growth factor signaling and basement membrane assembly are connected during epithelial morphogenesis of the embryoid body. J Cell Biol (2001) 1.58
The nucleotide sequence of rat alpha-tubulin: 3'-end characteristics, and evolutionary conservation. Nucleic Acids Res (1981) 1.58
"Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc Natl Acad Sci U S A (1985) 1.56
Analysis of recombinant DNA clones specific for the murine p53 cellular tumor antigen. EMBO J (1983) 1.55
Cooperation of lymphoid cells in an in vitro graft reaction system. The role of the thymus cell. Transplantation (1970) 1.54
Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315. Cold Spring Harb Symp Quant Biol (1977) 1.54
Nuclear membrane protein LAP2beta mediates transcriptional repression alone and together with its binding partner GCL (germ-cell-less). J Cell Sci (2001) 1.51
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia (2006) 1.50
Genetic control of the immune response: in vitro stimulation of lymphocytes by (T,G)-A--L, (H,G)-A--L, and (Phe,G)-A--L. J Exp Med (1974) 1.50
Correlated expression of VH framework and VH idiotypic determinants on T helper cells and on functionally undefined T cells binding group A streptococcal carbohydrate. Eur J Immunol (1980) 1.50
Developmental expression of the alpha receptor for platelet-derived growth factor, which is deleted in the embryonic lethal Patch mutation. Development (1992) 1.48
Chromosomal translocation (1:13) in a case of alveolar rhabdomyosarcoma. J Pediatr Hematol Oncol (1998) 1.48
Purification and properties of an enzyme from beef liver which catalyzes sulfhydryl-disulfide interchange in proteins. J Biol Chem (1966) 1.48
Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res (1988) 1.45
Malignant osteopetrosis manifested as juvenile chronic myeloid leukemia. Pediatr Hematol Oncol (1993) 1.44
Brief report: lymphoma with recurrent cycles of spontaneous remission and relapse--possible role of apoptosis. N Engl J Med (1995) 1.42
Infantile idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol (1990) 1.42
Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene (2010) 1.42
Promoter and enhancer elements in the rearranged alpha chain gene of the human T cell receptor. EMBO J (1987) 1.40
A specific combination of substrates is involved in signal transduction by the kit-encoded receptor. EMBO J (1991) 1.39
Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer (2007) 1.38
DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene (2001) 1.37
Mechanism of antigen binding by T cells. H-2(I-A)-restricted binding of antigen plus Ia by helper cells. Eur J Immunol (1980) 1.37
The chemical structure of the heavy chains of rabbit and human immunoglobulin G (IgG). Proc R Soc Lond B Biol Sci (1966) 1.36
The characterization and localization of the mouse thymopoietin/lamina-associated polypeptide 2 gene and its alternatively spliced products. Genome Res (1996) 1.33
Fgfr2 is required for limb outgrowth and lung-branching morphogenesis. Proc Natl Acad Sci U S A (1999) 1.33
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia (2008) 1.33
Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). Oncogene (1994) 1.31